Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough — Stella

Home/Chronic Cough/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Cough trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

Australia

The University of Melbourne, Parkville, Victoria

Key details

Phase

Very early testing

Sponsor

Stuart Mazzone

Collaborators

Merck Sharp & Dohme LLC, Melbourne Health

Enrollment target

~31 participants

Started

January 2024

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.